Bain Capital Life Sciences Investors, LLC Q3 2020 Filing
Filed November 16, 2020
Portfolio Value
$1.1T
Holdings
22
Report Date
Q3 2020
Filing Type
13F-HR
All Holdings (22 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SWTXSPRINGWORKS THERAPEUTICS INC | 7,281,307 | $347.1B | 32.35% | |
| 2 | ARQTARCUTIS BIOTHERAPEUTICS, INC. | 3,979,292 | $116.6B | 10.87% | |
| 3 | ANNXANNEXON INC | 3,241,628 | $98.0B | 9.13% | |
| 4 | —DICERNA PHARMACEUTICALS INC | 4,080,237 | $73.4B | 6.84% | |
| 5 | —MERSANA THERAPEUTICS, INC. | 3,445,667 | $64.2B | 5.98% | |
| 6 | REPLREPLIMUNE GROUP INC | 2,122,415 | $48.9B | 4.55% | |
| 7 | DVAXDYNAVAX TECHNOLOGIES CORP. | 10,895,773 | $47.1B | 4.39% | |
| 8 | NRIXNURIX THERAPEUTICS, INC. | 1,284,314 | $44.8B | 4.18% | |
| 9 | SG7SAGE THERAPEUTICS, INC. | 499,100 | $30.5B | 2.84% | |
| 10 | —CONSTELLATION PHARMACEUTICALS INC. | 1,400,000 | $28.4B | 2.64% | |
| 11 | KYMRKYMERA THERAPEUTICS INC. | 729,606 | $23.6B | 2.20% | |
| 12 | YB4PSAVARA INC | 5,128,593 | $23.0B | 2.14% | |
| 13 | AGLEUSDAEGLEA BIOTHERAPEUTICS, INC. | 2,700,000 | $19.1B | 1.78% | |
| 14 | —APTINYX INC | 5,558,425 | $18.8B | 1.75% | |
| 15 | —MARINUS PHARMACEUTICALS INC | 1,431,059 | $18.4B | 1.71% | |
| 16 | CRNXCRINETICS PHARMACEUTICALS, INC. | 1,071,428 | $16.8B | 1.56% | |
| 17 | —THERAPEUTICS ACQUISITION COR | 1,000,000 | $14.4B | 1.34% | |
| 18 | ASNSUSDX4 PHARMACEUTICALS INC | 1,648,485 | $11.2B | 1.04% | |
| 19 | —ARYA SCIENCES ACQUISITION CORP III | 1,000,000 | $10.8B | 1.01% | |
| 20 | SLDBSOLID BIOSCIENCES INC | 3,871,164 | $7.9B | 0.73% | |
| 21 | —BCTG ACQUISITION CORP | 500,000 | $5.2B | 0.48% | |
| 22 | —PANACEA ACQUISITION CORP | 500,000 | $5.0B | 0.47% |